Histopathologic examination of the sentinel lymph nodes

Breast Journal

Volumn 12, Issue SUPPL. 2, 2006, Pages

  Cserni, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Guidelines; Immunohistochemistry; Intraoperative assessment; Sentinel lymph nodes; Step sections

Indexed keywords

CYTOKERATIN;

ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRACTICE GUIDELINE; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPH NODES; PRACTICE GUIDELINES; SENTINEL LYMPH NODE BIOPSY;

EID: 33748346872     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00336.x     Document Type: Article

References (36)

1. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-46.
2. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
3. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004;240:462-68.
4. Braithwaite LR. The flow of lymph from the ileocaecal angle, and its possible bearing on the cause of duodenal and gastric ulcer. Br J Surg 1923;11:7-26.
5. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer 1960;13:77-78.
6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
7. Morton DL, Wen DR, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-99.
8. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-98.
10. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
11. Kett K, Varga G, Lukacs L. Direct lymphography of the breast. Lymphology 1970;1:3-12.
12. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;180:700-704.
13. Turner RR, Ollila D, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-67.
14. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work-up. J Clin Pathol 1999;52:922-24.
15. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-52.
16. Cserni G. Complete sectioning of axillary sentinel lymph nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-31.
17. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Handbook - TNM Classification of Malignant Tumors, 6th ed. New York: Springer-Verlag, 2002.
18. Sobin LH, Wittekind C, eds. UICC TNM Classification of Malignant Tumours, 6th ed. New York: John Wiley & Sons, 2002.
19. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the American Joint Committee on Cancer Staging Manual, 6th ed. Cancer 2003;98:2740-41.
20. Maiorano E, Mazzarol GM, Pruneri G, et al. Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003;27:513-18.
21. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003;39:1654-67.
22. Cserni G. Axillary staging of breast cancer and the sentinel node. J Clin Pathol 2000;53:733-41.
23. Zgajnar J, Frkovic-Grazio S, Besic N, et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients - results of a large series. J Surg Oncol 2004;85:82-86.
24. Richter T, Nahring J, Komminoth P, Kowolik J, Werner M. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol 1999;52:461-63.
25. Ku NN. Pathologic examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin N Am 1999;8:469-79.
26. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 2004;57:695-701.
27. Perry N, Broeders M, de Wolf C, et al., eds. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis, 4th ed. Luxembourg: European Communities, 2006.
28. Kuehn T, Bembenek A, Decker T, et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005;103:451-61.
29. Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol 2004;57:467-71.
30. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005;103:358-67.
31. Cserni G, Sapino A, Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 2006;15:347-54.
32. Fitzgibbons PL, Connolly JL, Page DL. Updated protocol for the examination of specimens from patients with carcinomas of the breast. Cancer Committee. Arch Pathol Lab Med 2000;12:1026-33.
33. Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19-22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33:579-89.
34. Pathology Reporting of Breast Disease. NHSBSP publication 58. Sheffield, UK: NHS Cancer Screening Programmes, 2005; available at http://www. cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-low-resolution.pdf.
35. Sentinel-Lymphknotenbiopsien. Graz, Austria: Osterreichische Gesellschaft fur Pathologie; available at http://www.pathology.at/sentinel.htm.
36. Australian Cancer Network Breast Pathology Working Party. The Pathology Reporting of Breast Cancer. A Guide for Pathologists, Surgeons, Radiologists and Oncologists. Recommendations of the Australian Cancer Network Working Party, 2nd ed. ACN Publication no. 7. Sidney: Australian Cancer Network, 2001; available at http://www.cancer.org.au/documents/ The_Pathology_reporting_of_breast_cancer_2001.pdf.